These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37081943)

  • 1. miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Retraction].
    Int J Nanomedicine; 2023; 18():2017-2018. PubMed ID: 37081943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum].
    Int J Nanomedicine; 2020; 15():8293-8294. PubMed ID: 33149576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.
    Li F; Wang F; Zhu C; Wei Q; Zhang T; Zhou YL
    Int J Nanomedicine; 2018; 13():2295-2307. PubMed ID: 29713162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Polymeric Nanoparticle Intracellular Targeting Overcomes Chemodrug Resistance in Human Primary Patient Breast Cancer Cells [Retraction].
    Int J Nanomedicine; 2022; 17():2555-2556. PubMed ID: 35685301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction].
    Int J Nanomedicine; 2022; 17():3581-3582. PubMed ID: 35983481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin-Loaded Solid Lipid Nanoparticle Attenuates Diabetic Nephropathy Induced by Streptozotocin Nicotinamide Through Nrf2/HO-1/NF-kB Signalling Pathway [Retraction].
    Int J Nanomedicine; 2022; 17():3457-3458. PubMed ID: 35959280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA-Loaded Poly(Histidine-Arginine)6-Modified Chitosan Nanoparticle with Enhanced Cell-Penetrating and Endosomal Escape Capacities for Suppressing Breast Tumor Metastasis [Retraction].
    Int J Nanomedicine; 2023; 18():1897-1898. PubMed ID: 37057189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3.
    Fisher L
    RSC Adv; 2021 Jan; 11(7):4166. PubMed ID: 35427002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-Enriched Nanofibrillated Cellulose/Poloxamer in-situ Forming Hydrogel Scaffolds as a Controlled Delivery System of Raloxifene HCl for Bone Engineering [Retraction].
    Int J Nanomedicine; 2021; 16():7773-7774. PubMed ID: 34853512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction].
    Onco Targets Ther; 2021; 14():123. PubMed ID: 33447053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c(RGDyK)-Decorated Pluronic Micelles for Enhanced Doxorubicin and Paclitaxel Delivery to Brain Glioma [Retraction].
    Int J Nanomedicine; 2022; 17():5603-5604. PubMed ID: 36444198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Nanoemulsion-Based Method to Produce Ultrasmall, Water-Dispersible Nanoparticles from Chitosan, Surface Modified with Cell-Penetrating Peptide for Oral Delivery of Proteins and Peptides [Retraction].
    Int J Nanomedicine; 2022; 17():1461-1462. PubMed ID: 35378883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma [Retraction].
    Cancer Manag Res; 2021; 13():8061-8062. PubMed ID: 34729025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-144 Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3295-3296. PubMed ID: 34040393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized Nanostructured Lipid Carriers Integrated into in situ Nasal Gel for Enhancing Brain Delivery of Flibanserin [Retraction].
    Int J Nanomedicine; 2023; 18():2253-2254. PubMed ID: 37143899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction].
    Onco Targets Ther; 2022; 15():145-146. PubMed ID: 35173447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3177. PubMed ID: 34040385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction: MiR-206 reduced the malignancy of hepatocellular carcinoma cells
    Fisher L
    RSC Adv; 2021 Jan; 11(8):4439. PubMed ID: 35426999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Characterization of a Novel Peptide-Grafted Cs and Evaluation of Its Nanoparticles for the Oral Delivery of Insulin, in vitro, and in vivo Study [Retraction].
    Int J Nanomedicine; 2020; 15():1623. PubMed ID: 32210556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis [Retraction].
    Onco Targets Ther; 2021; 14():5419-5420. PubMed ID: 34916805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.